Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
CBG-MEB · 4 medicines
FDA · 4 medicines
Anvisa · 2 medicines
EMA · 1 medicine
AIFA · 1 medicine
HSA · 1 medicine
TFDA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
25 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Rufinamide | United States | 100MG, 200MG, 400MG | tablet | Marketed | Aurobindo Pharma |
| Rufinamide | United States | 40MG/ML | suspension | Marketed | Aurobindo Pharma |
| Auro-Rufinamide | Canada | 200 MG | Tablet | Marketed | Auro Pharma INC |
| Auro-Rufinamide | Canada | 400 MG | Tablet | Marketed | Auro Pharma INC |
| Banzel | United States | 40MG/ML | suspension | Marketed | Eisai INC |
| Banzel | United States | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 200MG, 400MG | tablet | Marketed | Eisai INC |
| INOVELON 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | Spain | 100 mg | comprimido recubierto con película | Marketed | Eisai Gmbh |
| INOVELON 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | Spain | 200 mg | comprimido recubierto con película | Marketed | Eisai Gmbh |
| INOVELON 400 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | Spain | 400 mg | comprimido recubierto con película | Marketed | Eisai Gmbh |
| Inovelon | European Union | Authorised | Eisai GmbH | ||
| INOVELON 40 mg/ml SUSPENSION ORAL | Spain | 40 mg | suspensión oral | Marketed | Eisai Gmbh |
| Inovelon 100 mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Eisai GmbH | |
| Inovelon 200 mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Eisai GmbH | |
| Inovelon 400 mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Eisai GmbH | |
| Inovelon | Italy | Compressa rivestita con film | Authorised | Eisai GMBH | |
| Inovelon 40 mg/ ml, suspensie voor oraal gebruik | Netherlands | Suspensie voor oraal gebruik | Authorised | Eisai GmbH | |
| Banzel | Canada | 400 MG | Tablet | Marketed | Eisai Limited |
| Banzel | Canada | 100 MG | Tablet | Marketed | Eisai Limited |
| Banzel | Canada | 200 MG | Tablet | Marketed | Eisai Limited |
| Inovelon | Brazil | Authorised | United Medical Ltda | ||
| Inovelon Film-Coated Tablet 200 MG | Singapore | 200 mg | tablet, film coated | Authorised | Eisai (Singapore) Pte. LTD. |
| Inovelon Film-coated Tablets 100 mg | Taiwan | 膜衣錠 | Authorised | 衛采製藥股份有限公司 | |
| Inovelon | Croatia | Authorised | |||
| Banzel | Canada | 40 MG / ML | Suspension | Cancelled | Eisai Limited |
| Inovelon | Brazil | Cancelled | Eisai Laboratórios Ltda |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
